loadpatents
Patent applications and USPTO patent grants for Chang; Rong-Kun.The latest application filed is for "once daily formulations of tetracyclines".
Patent | Date |
---|---|
Once Daily Formulations Of Tetracyclines App 20220016041 - Chang; Rong-Kun ;   et al. | 2022-01-20 |
Stabilized Formulations Of Cns Compounds App 20210322429 - Chang; Rong-Kun ;   et al. | 2021-10-21 |
Stabilized formulations of CNS compounds Grant 11,077,114 - Chang , et al. August 3, 2 | 2021-08-03 |
Once Daily Formulations Of Tetracyclines App 20190125683 - Chang; Rong-Kun ;   et al. | 2019-05-02 |
Stabilized Formulations Of Cns Compounds App 20190060323 - CHANG; Rong-Kun ;   et al. | 2019-02-28 |
Stabilized formulations of CNS compounds Grant 10,149,853 - Chang , et al. Dec | 2018-12-11 |
Electrostatic discharge protection apparatus Grant 9,780,085 - Chang , et al. October 3, 2 | 2017-10-03 |
Once Daily Formulations of Tetracyclines App 20160113880 - Chang; Rong-Kun ;   et al. | 2016-04-28 |
Less abusable pharmaceutical preparations Grant 9,308,176 - Chang April 12, 2 | 2016-04-12 |
Drug formulations having reduced abuse potential Grant 9,144,551 - Chang , et al. September 29, 2 | 2015-09-29 |
Drug Formulations Having Reduced Abuse Potential App 20150150816 - CHANG; Rong-Kun ;   et al. | 2015-06-04 |
Stabilized Formulations Of Cns Compounds App 20150086629 - Chang; Rong-Kun ;   et al. | 2015-03-26 |
Once Daily Formulations Of Tetracyclines App 20150057254 - Chang; Rong-Kun ;   et al. | 2015-02-26 |
Drug formulations having reduced abuse potential Grant 8,906,413 - Chang , et al. December 9, 2 | 2014-12-09 |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics Grant 8,808,714 - Chang , et al. August 19, 2 | 2014-08-19 |
Stabilized formulations of CNS compounds Grant 8,748,472 - Chang , et al. June 10, 2 | 2014-06-10 |
Once daily formulations of tetracyclines Grant 8,709,478 - Chang , et al. April 29, 2 | 2014-04-29 |
Once Daily Formulations Of Tetracyclines App 20140072626 - Chang; Rong-Kun ;   et al. | 2014-03-13 |
Once daily formulations of tetracyclines Grant 8,470,364 - Chang , et al. June 25, 2 | 2013-06-25 |
Once daily formulations of tetracyclines Grant 8,394,405 - Chang , et al. March 12, 2 | 2013-03-12 |
Once daily formulations of tetracyclines Grant 8,394,406 - Chang , et al. March 12, 2 | 2013-03-12 |
Once daily formulations of tetracyclines Grant 8,206,740 - Chang , et al. June 26, 2 | 2012-06-26 |
Once daily formulations of tetracyclines App 20110319368 - Chang; Rong-Kun ;   et al. | 2011-12-29 |
Once daily formulations of tetracyclines App 20110294759 - Chang; Rong-Kun ;   et al. | 2011-12-01 |
Once daily formulations of tetracyclines App 20110288056 - Chang; Rong-Kun ;   et al. | 2011-11-24 |
Stabilized Formulations Of Cns Compounds App 20110244042 - CHANG; Rong-Kun ;   et al. | 2011-10-06 |
Use of a mixture of two or more enteric materials to regulate drug release via membrance or matrix for systemic therapeutics App 20110212156 - Chang; Rong-Kun ;   et al. | 2011-09-01 |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics Grant 7,910,128 - Chang , et al. March 22, 2 | 2011-03-22 |
Oral pulsed dose drug delivery system Grant RE42,096 - Burnside , et al. February 1, 2 | 2011-02-01 |
Once daily formulations of tetracyclines Grant 7,749,532 - Chang , et al. July 6, 2 | 2010-07-06 |
Oral pulsed dose drug delivery system Grant RE41,148 - Burnside , et al. February 23, 2 | 2010-02-23 |
Once daily formulations of tetracyclines App 20090011006 - Chang; Rong-Kun ;   et al. | 2009-01-08 |
Absorption Enhancing Agents App 20070249537 - CHANG; Rong-Kun ;   et al. | 2007-10-25 |
Drug formulation and delivery using crystalline methylated cyclodextrins Grant 7,259,153 - Chang August 21, 2 | 2007-08-21 |
Less abusable pharmaceutical preparations App 20060083690 - Chang; Rong-Kun | 2006-04-20 |
Sustained release delivery of amphetamine salts App 20050158384 - Couch, Richard A. ;   et al. | 2005-07-21 |
Sustained release delivery of amphetamine salts Grant 6,913,768 - Couch , et al. July 5, 2 | 2005-07-05 |
Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers Grant 6,890,918 - Burnside , et al. May 10, 2 | 2005-05-10 |
Drug formulations having reduced abuse potential App 20040228802 - Chang, Rong-Kun ;   et al. | 2004-11-18 |
Once daily formulations of tetracyclines App 20040228912 - Chang, Rong-Kun ;   et al. | 2004-11-18 |
Oral pulsed dose drug delivery system App 20040219213 - Burnside, Beth A. ;   et al. | 2004-11-04 |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,811,794 - Burnside , et al. November 2, 2 | 2004-11-02 |
Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem App 20040202693 - Chang, Rong-Kun | 2004-10-14 |
Solid oral dosage form Grant 6,793,934 - Burnside , et al. September 21, 2 | 2004-09-21 |
Absorption enhancing agents App 20040167203 - Chang, Rong-Kun ;   et al. | 2004-08-26 |
Drug formulation and delivery using crystalline methylated cyclodextrins App 20040157797 - Chang, Rong-Kun | 2004-08-12 |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics App 20040142035 - Chang, Rong-Kun ;   et al. | 2004-07-22 |
Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles App 20040062800 - Burnside, Beth A. ;   et al. | 2004-04-01 |
Sustained release delivery of amphetamine salts App 20040059002 - Couch, Richard A. ;   et al. | 2004-03-25 |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles App 20030158261 - Burnside, Beth A. ;   et al. | 2003-08-21 |
Oral pulsed dose drug delivery system Grant 6,605,300 - Burnside , et al. August 12, 2 | 2003-08-12 |
Oral pulsed dose drug delivery system App 20030124188 - Burnside, Beth A. ;   et al. | 2003-07-03 |
Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers App 20030096761 - Burnside, Beth ;   et al. | 2003-05-22 |
Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle App 20030065040 - Shojaei, Amir H. ;   et al. | 2003-04-03 |
Rapid immediate release oral dosage form Grant 6,384,020 - Flanner , et al. May 7, 2 | 2002-05-07 |
Oral Pulsed Dose Drug Delivery System App 20010055613 - BURNSIDE, BETH A. ;   et al. | 2001-12-27 |
Oral pulsed dose drug delivery system Grant 6,322,819 - Burnside , et al. November 27, 2 | 2001-11-27 |
Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,287,599 - Burnside , et al. September 11, 2 | 2001-09-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.